Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

Life Sciences key contacts

News and updates
-
Avison Young appoints Chris Pilgrim as UK head of Capital Markets11 August 2025
-
Avison Young brings high-rise residential development opportunity in Leeds city centre to market29 July 2025
-
Regional office markets see strongest H1 take-up since 201924 July 2025
-
Blackpool’s renowned leisure destination North Pier brought to market22 July 2025